Tetralogy of Fallot (TOF) is a structural congenital heart defect with functional significance, occurring 1 in 3,300 live births. Several studies have reported mutations in essential transcription factors responsible for the development of TOF. NKX2.5 is a homeobox containing transcription factor, expresses at various stages of heart development. The rationale of this study was to estimate the frequency of NKX2.5 Arg25Cys mutation in TOF children from India. Using PCR-RFLP the frequency was estimated in TOF and controls. Clinical characteristics and maternal data from 84 unrelated TOF patients was collected and evaluated in comparison with 117 healthy individuals. TOF patients were tested for 22q11.2 micro deletion for the inclusion of sporadic cases. In 6% of TOF cases (n=84) a positive family history of congenital heart defects was revealed and 85.7% of children had various clinical symptoms. Significant reproductive history such as abortions, intrauterine and perinatal deaths were seen in 31% (n=26) of patient's mothers. NKX2.5 Arg25Cys mutation was observed only in TOF children with a frequency of 5.9% TT (homozygous) and 10.7% CT (heterozygous) respectively. None of the controls showed the presence of mutation. Hence the present study concludes that the mutation Arg25Cys was segregated with disease pathology with reduced penetrance and variable expressivity.
Introduction
Embryonic heart development in humans is the foremost critical and complex process involving controlled expression of numerous developmental genes via series of combined molecular and morphogenetic events [1] . Failure to proper coordination of these mechanisms during embryogenesis results in deleterious phenotypes called congenital heart defects (CHD) as evidenced from earlier studies [2] . The increased risk for parents with an affected child suggests the potential risk for inherited predisposing mutations due to genetic heterogeneity. The anatomic or structural heart defect reflects the function of the mutated gene(s) during cardiac development and some genes impinge on several developmental pathways [3] . Tetralogy of Fallot (TOF) is one of the common cyanotic congenital heart defects, representing 55-70% and causes blue baby syndrome. TOF occurs in approximately 3 to 6 per 10,000 births, significantly in 5-7% of total CHDs [4] and affects both genders equally. The deviation of conal septum is known as monology of TOF, is associated with ventricular septal defect (VSD), right ventricular outflow tract obstruction (RVOTO), overriding of aorta and right ventricular hypertrophy (RVH) developed essentially
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during cardiac embryogenesis. The recent findings of candidate genes responsible for CHDs have provided new insights into the genetic basis of heart malformation in humans especially mutations in genes that control the development of the heart [5] .
Homeobox-containing genes play critical roles in regulating tissue-specific gene expression critical for tissue differentiation, in determining the temporal and spatial patterns of development [6] . NKX2.5 gene encodes for an evolutionarily conserved homeobox containing transcription factor effectively functions for cardiac morphogenesis. The functional significance of NKX gene for heart formation and development was observed both in animals and humans [7] . The gene is localized to chromosome 5q34 and consists of 2 exons of size 510bp and 1075bp which encodes a 324 amino acid protein [8, 9] . Earlier studies evaluated the prevalence of NKX2.5 mutations in TOF and in various forms of CHD [10] [11] [12] . In CHDs, several mutations have been identified in homeodomain and non-homeodomain region of NKX2.5 gene. In TOF, the non-homeodomain mutation Arg25Cys was first reported by McElhinney et al [12] . Further, many studies have described the alteration Arg25Cys in the first exon of NKX2.5 gene to be the most common change in TOF [10, 13, 14] . Some studies have indicated the presence of Arg25Cys alteration in healthy subjects and predict that alteration Arg25Cys might be a polymorphic change [14, 15] .
The locus 22q11.2 is the most important genetic determinant of DiGeorge/22q11.2 deletion syndrome. Many studies concluded that patients with TOF have significantly higher percent of 22q11.2 micro deletion compare to other major CHDs [16] [17] [18] . In India, the frequency of 22q11.2 micro deletion in TOF was found to be ~4-6% [19, 20] . Hence it is important to rule out 22q11.2 micro deletion to make sure all cases present in the study were sporadic. In view of the aforementioned studies and lack of frequency of NKX2.5 Arg25Cys mutation in particular, we rather tried to establish the frequency of this mutation typically in non syndromic cases of TOF who did not show 22q11.2 micro deletion. The present study determines whether this variant is a naturally occurring polymorphism, or a mutation that may be responsible for TOF.
Materials and Methods

Selection criteria for patient and control group
Eighty four children with Tetralogy of Fallot (n=84), referred from the Division of Pediatric Cardiology, CARE Hospital, Hyderabad, India; from the period 2005 -2008, were recruited randomly for the study group. One hundred and seventeen age and sex matched healthy children, with no family history of CHD and other associated genetic diseases were taken as control group. The present study was carried out in accordance with the ethical standards approved by ethics committee of CARE Hospital, Hyderabad, India. Informed and educated consent to participate in the study was taken from the parents of all TOF patients and healthy controls. Clinical diagnosis of TOF was based on the two dimensional echocardiography. Demographic data, maternal and sibling history, clinical features and other associated abnormalities were collected.
Only non syndromic children with TOF with age >12 months were included in the study. Healthy and age matched control children with no history of heart disease and with normal karyotype formed the control group. Children with syndromes and abnormal chromosomal karyotype (22q11 micro deletion), those who had undergone blood transfusion, babies below one year, and babies with lack of consent from parents, baby being delicate or sick and those with specific infections like rubella were excluded from the study.
Collection of Blood Samples
Peripheral blood sample (5mL) was collected from each child to carryout chromosomal analysis and for screening NKX2.5 Arg25Cys mutation. Blood samples from control infants were collected from Institute of Genetics, Division of Pediatrics, CARE hospital and also from healthy voluntary school children. All samples were collected with prior informed and educated consent from the parents.
Chromosomal culture and karyotype
Cytogenetic analysis was carried for identifying structural and numerical chromosomal aberrations, according to standard methods from cultured peripheral blood lymphocytes [21] and trypsin GTG banding [22] with minor laboratory modifications. Twenty metaphase spreads were examined under microscope for the karyotype analysis according to ISCN guidelines [23] .
Fluorescence in situ Hybridization
FISH (Fluorescence in situ hybridization) analysis was carried on interphase and metaphase cells according to manufactures instructions (Cytocell aquarius Ltd, UK) using DiGeorge deletion region probe to confirm the presence/absence of 22q11.2 micro deletion. In brief, lymphocyte culture slides were prepared by spotting cell sample onto cleaned frosted microscopic slide. Then the slides were immersed in 2X SSC (pH 7.0) for 2 minutes and dehydrated in an ethanol series (70%, 85% and 100%), each for 2 minutes respectively. 10µL of probe was taken and placed on cell sample slide, covered with a 24X24 mm glass cover slip, sealed with rubber solution glue and allowed to dry. Slides were then placed on to a 75 0 C (+/-1 ºC) hot plate and denatured for 45 seconds followed by hybridization in a humid, lightproof container at 37 0 C for overnight. Subsequently, the slides were washed in SSC for 2 minutes and DAPI antifade was added. The slides were covered with a coverslip and allowed to develop in the dark for 10 minutes and observed under fluorescence microscope at a 100W mercury lamp and plane apochromat objectives at X63 and/or X100.
Genomic DNA isolation
Genomic DNA was extracted by phenol-chloroform method as described by Blin and Stafford [24] . In short, WBCs were isolated from venous blood samples using erythrocyte lysis buffer (155mM ammonium chloride, 7.23mM potassium carbonate, 0.5M EDTA) and incubated (37 0 C) along with 20mg/mL Proteinase K and 20% SDS. After, 5mL of Tris equilibrated phenol (pH=8) was added and centrifuged at 1000g for 10 minutes. To the supernatant 5mL of phenol: chloroform: isoamyl alcohol (25:24:1) was added and centrifuged at 1000g for 10 minutes. Further, to the supernatant 5mL of chloroform: isoamyl alcohol (24:1) was added and centrifuged at 1000g for 15 minutes. DNA was precipitated with chilled absolute alcohol and dissolved in Tris-EDTA buffer. DNA was stored at -20 0 C for further analysis.
Polymerase chain reaction
PCR amplification of NKX2.5 exon1 (489bp) was executed with 100ng of genomic DNA in a total volume of 50μL containing 20pmol each of forward primer -5'GTCCCGCCTCTCCTGCCCCTTGTG-3' and reverse primer -5'AGGGTCCTTGGCTGGGTCGG3', along with 10mM dNTPs, 3U Taq DNA polymerase in 10X PCR buffer. The amplification was performed in MJ mini thermal cycler and PCR conditions were as follows: initial denaturation at 95°C for 10 min, followed by 35 cycles of denaturation (95 °C for 1min), annealing (65°C for 1min), extension (72°C for 2min). The final extension step was set for 72 0 C for 5 minutes.
Restriction fragment length polymorphism
The PCR products from matched control samples and patients were analyzed for the variant 73CT in the NKX2.5 gene. RFLP analysis was carried out using conventional HhaI restriction enzyme [25] . The restriction enzyme digest includes restriction buffer, 3 U of HhaI, 10µl of PCR product, and sterile water to give a total reaction volume of 20µl. The reaction mixtures were incubated at 65°C for 2hours followed by electrophoresis. 
Results
Children with Tetralogy of Fallot (n=84) and healthy controls (n=117) were analyzed for variation NKX2.5 73C→T by RFLP-PAGE using HhaI. Evaluation of frequency of age and sex of children with TOF indicated that TOF was more frequently observed in males (54.8%) than female children (45.2%). The general characteristics of TOF patients associated heart defects and inheritance are represented in the table1. The results indicate that, sporadic and non syndromic cases of TOF were more frequent and observed in 94% of the cases, while, family history of congenital heart defects was seen only in 6% of patients.
Maternal factors such as age, reproductive history, consanguinity and other lifestyle factors (smoking and alcohol consumption) are known to be risk factors for the development of birth defects including congenital heart defects. Hence the role of these factors in the Induction of TOF was studied (Table 2) . TOF children were born mostly to mothers who were very young, between 15-20 years of age (42.8%), followed by mothers in the age group of 21-25 years (38.09%). Further 31% of mothers presented with different types of reproductive and pregnancy complications including abortions (17.85%) and neonatal deaths (7.14%). Maternal infections were rare (2.38%). None of the mothers were active smokers and never consumed alcohol. The role of consanguinity in the etiology of TOF revealed that first-cousin marriages were frequent (17.85%) when compared to uncle-niece marriages (3.57%) and second cousins (2.38%). Third degree and fifth degree relationships were observed in 21% and 3% respectively. However, the frequency of consanguinity is similar to that observed in Indian population and hence has no major role to play in the induction of TOF.
Evaluation of chromosomal abnormalities in TOF patients by conventional GTG banding ( Figure 1A ) and FISH analysis was attempted to exclude syndromic cases showing 22q11.2 micro deletion ( Figure 1B) . Cytogenetic analysis of all the 84 patients included were normal for chromosomal karyotype and FISH. These findings helped in defining the patients to be cytogenetically non syndromic and for further molecular analysis. Exon 1 region of NKX2.5 gene was screened for variation 73C→T by RFLP analysis (PAGE) using Hha1 in both healthy control children and patients with TOF. The results indicated that the nucleotide variation co-segregated with TOF condition and was absent in the DNA of 117 control individuals (Table 3 ). Out of 84 TOF patients 83.3% (n=70) were wild type (CC), 10.7% (n=9) were heterozygotes (CT) and 5.95% (n=5) were homozygotes (TT) for the mutation. In the figure 2b the PAGE gel picture represents the presence of all three genotypes in which mutant genotypes are specific only for TOF. All control children showed wild type CC genotype. NKX2.5 73C→T mutation results in the substitution of arginine to cystein at residue 25 of the protein (Arg25Cys).
1A
1B Figure 1A shows G Banding metaphase and Karyotype. Figure 1B shows locus 22q11 FISH interphase and metaphase cells obtained from peripheral blood lymphocyte culture. 
Discussion
Cardiac transcription factors are essential transcriptional activators that are expressed predominantly in heart and regulate the expression of the cardiac genes encoding structural proteins or regulatory proteins characteristic of cardiomyocytes [26] . NKX2.5 is the earliest known marker for myocardial progenitor cells in all species in which it has been studied. Reports have indicated that mutation of drosophila NKX2.5 homolog tinman, results in failure of heart formation [27] . Similarly, homozygous inactivation of NKX2.5 in mammals results in impaired cardiac looping and embryonic lethality while heterozygous condition results in various abnormalities [12] . NKX2.5 is known to play a central role in the determination of myocardial cell fate and it is important during postnatal life. Hence, there has been considerable interest in the potential role of NKX2.5 in human cardiac development and disease. Identification of human mutations that cause congenital heart disease offers a complementary approach to gene ablation studies and particularly fosters definition of gene defects that perturb later stages of cardiac development.
Previous reports have described the association of mutations in different sites of NKX2.5 gene, both in exon 1 and exon 2 with various congenital cardiac defects [28, 29] . The variant 73C→T in exon1 was reported to be specific for non syndromic TOF [10, 12, 13] . Similar findings were observed in the present study and the variant 73C→T was detected only in patients with TOF. The prevalence of variation in the present study was found to be 5.95% in homozygotes (TT) and 10.7% in heterozygous patients (CT). The overall frequency of the genotype TT and CT put together was observed to be higher than the prevalence reported earlier. Previous studies indicated the frequency of 73C→T variation to be 2% [12] , 1.6% [14] (1/72 cases with conotruncal heart defects). Benson et al [13] reported an overall frequency of NKX2.5 mutations in 4% of the CHD patients and only 5% patients of TOF had 73C→T variation. In contrast Goldmuntz et al [10] indicates a higher frequency of 73C→T variation in TOF subjects (15.4%, 2/13). Further, in the present study none of the control subjects showed the presence of the mutation. Similarly, McElhinney et al [12] reported the absence of the variation in 50 Caucasian control subjects. The presence of variation 73C→T was shown in healthy controls in different ethnic groups [10, 14, 15] .
The nucleotide variation 73C→T corresponds to change arginine to cysteine (Arg25Cys) at residue 25 in the protein of NKX2.5 transcription factor [10] . This variant alters the charge of an amino acid from basic to neutral nature and is highly conserved between species. Arg25Cys is a missense mutation and present outside the homeodomain region in the amino terminus of the nonhomeodomain region [12] . The Arg25 residue does not lie within a functional domain of NKX2-5, according to secondary structure prediction with the protein forecasting (PROF) algorithm. Arg25 is just outside the first helix region of NKX2-5 spanning residues 14 to 24. The highly charged nature of arginine also dictates solvent accessibility [14] .
Through a complex mechanism NKX2.5 seems to be regulating precise target gene activation at each developmental stage. Kasahara et al [28] showed that Arg25Cys mutation appeared to function similarly to the wild type NKX2.5 and normal nuclear localization and normal binding to the monomeric DNA binding sites. However, a threefold higher concentration of mutant protein was required for equal distribution for binding to monomeric and dimeric DNA binding sites, suggesting a slight impairment of dimerization by the mutant NKX2.5. In contrast, protein with an intact homeodomain that carried the Arg25Cys mutation had normal transcriptional activity and normal DNA binding to a monomeric site but 3-fold to 9-fold reduction in DNA binding to dimeric sites [10] . Several lines of evidence suggest that NKX2.5 mutations are mostly somatic in nature, originating most likely from cell division errors. The presence of multiple non synonymous mutations in same patients confirms this contention [29] . Failure of cardiac transcription factor networks resulting from genetic instability in cardiac cells may be a plausible pathway for development of congenital heart disease. NKX2.5 is likely to form multi factor complexes to transactivate the target genes [27, 30] , and these factors in each complex could be different depending on the context of the target site.
The present study indicates that the mutation may be penetrant with variable expressivity in the disease patients. The higher frequency of the mutant allele/ genotype in the present study might be due to genetic diversity and ethnic variation. Hence, NKX2.5 could be the possible candidate gene for the diagnosis of TOF. Further, identification and screening of mutations will provide insight into the potential role of the Nkx2.5 gene in the development of TOF.
